Statutory rebates and fees for brand medicines by component U.S. 2020

Total statutory rebates and fees for brand medicines in the U.S. from 2013 to 2020, by component (in billion U.S. dollars)

Total statutory rebates and fees for brand medicines in US by component 2013-2020

Last update:

Jan 31, 2022

Author:

��ƽ�� Research Department

Region:

United States

Survey time period:

From 01/01/2013 to 31/12/2020

The total statutory rebates and fees for brand medicines of the Medicaid drug rebate program in 2020 was recorded at 34.1 billion U.S. dollars, up from 15.6 billion U.S. dollars in 2013. The statistic describes the total statutory rebates and fees for brand medicines in the U.S. from 2013 to 2020, by component.

We’re happy to help

Get in touch with us for additional information

Feel free to contact us anytime. We will respond to your inquiry as quickly as possible.

Get in touch

�����ƽ��

Total statutory rebates and fees for brand medicines in the U.S. from 2013 to 2020, by component (in billion U.S. dollars)

Get in touch with us for additional information

��ƽ��